Your browser doesn't support javascript.
loading
A therapeutic Porphyromonas gingivalis gingipain vaccine induces neutralising IgG1 antibodies that protect against experimental periodontitis.
O'Brien-Simpson, Neil M; Holden, James A; Lenzo, Jason C; Tan, Yan; Brammar, Gail C; Walsh, Katrina A; Singleton, William; Orth, Rebecca K H; Slakeski, Nada; Cross, Keith J; Darby, Ivan B; Becher, Dorit; Rowe, Tony; Morelli, Adriana Baz; Hammet, Andrew; Nash, Andrew; Brown, Anna; Ma, Bing; Vingadassalom, Didier; McCluskey, Jacqueline; Kleanthous, Harold; Reynolds, Eric C.
Afiliação
  • O'Brien-Simpson NM; Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.
  • Holden JA; Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.
  • Lenzo JC; Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.
  • Tan Y; Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.
  • Brammar GC; Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.
  • Walsh KA; Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.
  • Singleton W; Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.
  • Orth RKH; Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.
  • Slakeski N; Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.
  • Cross KJ; Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.
  • Darby IB; Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.
  • Becher D; CSL Ltd., Bio21 Institute, Parkville, VIC, Australia.
  • Rowe T; CSL Ltd., Bio21 Institute, Parkville, VIC, Australia.
  • Morelli AB; CSL Ltd., Bio21 Institute, Parkville, VIC, Australia.
  • Hammet A; CSL Ltd., Bio21 Institute, Parkville, VIC, Australia.
  • Nash A; CSL Ltd., Bio21 Institute, Parkville, VIC, Australia.
  • Brown A; Sanofi Pasteur, Cambridge, MA, USA.
  • Ma B; Sanofi Pasteur, Cambridge, MA, USA.
  • Vingadassalom D; Sanofi Pasteur, Cambridge, MA, USA.
  • McCluskey J; Sanofi Pasteur, Cambridge, MA, USA.
  • Kleanthous H; Sanofi Pasteur, Cambridge, MA, USA.
  • Reynolds EC; Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.
NPJ Vaccines ; 1: 16022, 2016.
Article em En | MEDLINE | ID: mdl-29263860
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: NPJ Vaccines Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: NPJ Vaccines Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália